谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Differences in Pharmacological Property Between Combined Therapy of the Vasopressin V2-receptor Antagonist Tolvaptan Plus Furosemide and Monotherapy of Furosemide in Patients with Hospitalized Heart Failure.

Koji Takagi,Naoki Sato,Shiro Ishihara,Hayano Iha,Noriyuki Kobayashi,Yusuke Ito,Tsuyoshi Nohara,Satoru Ohkuma,Tatsuya Mitsuishi,Atsushi Ishizuka,Shota Shigihara,Michiko Sone,Kenji Nakama,Hideo Tokuyama,Toshiya Omote,Arifumi Kikuchi,Shunichi Nakamura,Eisei Yamamoto,Masahiro Ishikawa,Kenichi Amitani,Naoto Takahashi,Yuji Maruyama,Hajime Imura,Wataru Shimizu

Journal of cardiology（2020）

引用 5|浏览30
关键词
Heart failure,Furosemide,Tolvaptan,Fluid compartments
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要